ImmunityBio, Inc. (IBRX)
7.92
+0.20
(+2.59%)
USD |
NASDAQ |
Sep 11, 16:00
7.95
+0.03
(+0.38%)
After-Hours: 16:28
ImmunityBio Gross Profit (TTM) : 148.09M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 148.09M |
| March 31, 2026 | 123.97M |
| December 31, 2025 | 97.01M |
| September 30, 2025 | 66.39M |
| June 30, 2025 | 40.10M |
| March 31, 2025 | 14.34M |
| December 31, 2024 | -2.809M |
| September 30, 2024 | -10.65M |
| June 30, 2024 | -16.80M |
| March 31, 2024 | -19.72M |
| December 31, 2023 | -21.12M |
| September 30, 2023 | -23.50M |
| June 30, 2023 | -24.86M |
| March 31, 2023 | -24.48M |
| December 31, 2022 | -23.95M |
| September 30, 2022 | -17.15M |
| June 30, 2022 | -11.29M |
| March 31, 2022 | -5.394M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -2.226M |
| June 30, 2021 | -4.558M |
| March 31, 2021 | -6.824M |
| December 31, 2020 | -9.02M |
| September 30, 2020 | -8.994M |
| Date | Value |
|---|---|
| June 30, 2020 | -8.852M |
| March 31, 2020 | -8.151M |
| December 31, 2019 | -8.969M |
| September 30, 2019 | -6.769M |
| June 30, 2019 | -4.579M |
| March 31, 2019 | -3.014M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.06M |
| September 30, 2015 | 0.06M |
| June 30, 2015 | 0.224M |
| March 31, 2015 | 0.224M |
| December 31, 2014 | 0.164M |
| March 31, 2014 | 0.164M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Moderna, Inc. | 280.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |